Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 4,417,000 | 4,767,000 | 4,889,000 | 4,532,000 | 5,157,000 |
| Cost of Goods | 1,404,000 | 1,483,000 | 1,483,000 | 1,367,000 | 1,665,000 |
| Gross Profit | 3,013,000 | 3,284,000 | 3,406,000 | 3,165,000 | 3,492,000 |
| Operating Expenses | 2,258,000 | 2,342,000 | 2,387,000 | 2,179,000 | 2,481,000 |
| Operating Income | 755,000 | 942,000 | 1,019,000 | 986,000 | 1,011,000 |
| Other Income | -135,000 | 684,000 | 111,000 | -58,000 | 28,000 |
| Pre-tax Income | 620,000 | 1,626,000 | 1,130,000 | 928,000 | 1,039,000 |
| Income Tax | 116,000 | 507,000 | -21,000 | 268,000 | 766,000 |
| Net Income Continuous | 349,000 | 964,000 | 991,000 | 538,000 | 139,000 |
| Net Income Discontinuous | 150,000 | N/A | 13,000 | -5,000 | N/A |
| Net Income | $499,000 | $964,000 | $1,004,000 | $533,000 | $139,000 |
| EPS Basic Total Ops | 0.26 | 0.49 | 0.51 | 0.27 | 0.07 |
| EPS Basic Continuous Ops | 0.18 | 0.49 | 0.51 | 0.27 | 0.06 |
| EPS Basic Discontinuous Ops | 0.08 | N/A | 0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.26 | 0.49 | 0.50 | 0.27 | 0.07 |
| EPS Diluted Continuous Ops | 0.18 | 0.49 | 0.50 | 0.27 | 0.06 |
| EPS Diluted Discontinuous Ops | 0.08 | N/A | 0.01 | 0.00 | 0.00 |
| EBITDA(a) | $994,000 | $1,159,000 | $1,249,000 | $1,229,000 | $1,266,000 |